Immunocore Holdings PLC reports results for the quarter ended in March - Earnings Summary
08/05/2024 14:16
* Immunocore Holdings PLC IMCR.OQ reported a quarterly
adjusted
loss of 49 cents per share for the quarter ended in March,
lower than the same quarter last year, when the company reported
EPS of -43 cents. The mean expectation of seventeen analysts
for the quarter was for a loss of 37 cents per share. Wall
Street expected results to range from -52 cents to -10 cents per
share.
* Revenue rose 30.3% to $70.50 million from a year ago;
analysts
expected $71.38 million.
* Immunocore Holdings PLC's reported EPS for the quarter was
a
loss of 49 cents.
* The company reported a quarterly loss of $24.44 million.
* Immunocore Holdings PLC shares had fallen by 6.1% this
quarter and lost 10.7% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 9.5%
in the last three months.
* In the last 30 days, there have been no negative revisions
of
earnings estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 17 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"
Wall Street's median 12-month price target for Immunocore
Holdings PLC is $89.50
This summary was machine generated from LSEG data May 8 at 01:16
p.m. UTC. All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 -0.37 -0.49 Missed
Dec. 31 2023 -0.28 -0.40 Missed
Sep. 30 2023 -0.35 0.05 Beat
Jun. 30 2023 -0.41 -0.36 Beat